New Zealand Cardiac Surgery National Report 2016
This report of the New Zealand National Cardiac Surgery Registry (NZCS) covers the period of 1 January 2016 to 31 December 2016.
The report includes all cardiac surgical procedures undertaken at the 5 District Health Boards (DHBs) performing publicly-funded cardiac surgery in New Zealand (Auckland, Waikato, Capital and Coast, Canterbury, Southern).
This is our second annual report of the National Cardiac surgical services in New Zealand. The report has been an accomplishment for all involved to be proud of. It is encouraging to note that data completeness has improved for 2016 across all units. This is a credit to the time and diligence of all members of the cardiac surgical units at the 5 DHBs. With the implementation of mobile devices in 2017 we expect the processes to become further streamlined. I take this opportunity to thank all the effort of the different teams involved in making this possible at both a National and Local level. The data in itself is a testimony to the quality of cardiac surgical service being provided around the country.
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


